Distinct Serum Cytokine Profiles in Neuromyelitis Optica and Multiple Sclerosis

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Interferon and Cytokine Research

• Publication date

  2013-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1089/jir.2012.0040PMID 23398365
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Increased memory Th17 cells in patients with neuromyelitis optica and multiple sclerosis.

  2011cited by this paper
• Interleukin-17-secreting T cells in neuromyelitis optica and multiple sclerosis during relapse.

  2011cited by this paper
• The rescue effect of plasma exchange for neuromyelitis optica.

  2011cited by this paper
• Different responses to interferon beta‐1b treatment in patients with neuromyelitis optica and multiple sclerosis

  2010cited by this paper
• T helper type 1 and 17 cells determine efficacy of interferon-β in multiple sclerosis and experimental encephalomyelitis

  2010cited by this paper
• Interferon Beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers.

  2010cited by this paper
• Neuromyelitis optica‐IgG in idiopathic inflammatory demyelinating disorders amongst Hong Kong Chinese

  2009cited by this paper
• Peripheral Immune Response in Pulmonary Tuberculosis

  2009cited by this paper
• Devic’s neuromyelitis optica and pregnancy: distinction from multiple sclerosis is essential

  2009cited by this paper
• Markedly increased CSF interleukin-6 levels in neuromyelitis optica, but not in multiple sclerosis

  2009cited by this paper
• The pathological spectrum of CNS inflammatory demyelinating diseases

  2009cited by this paper
• Interferon-β1b Treatment in Neuromyelitis Optica

  2009cited by this paper
• B cells and autoantibodies in the pathogenesis of multiple sclerosis and related inflammatory demyelinating diseases.

  2008cited by this paper
• Mouse Models of Experimental Autoimmune Uveitis

  2008cited by this paper
• Neuromyelitis optica: Diagnosis, pathogenesis, and treatment

  2008cited by this paper
• Neuromyelitis Optica (NMO) Antibody Positivity in Patients with Transverse Myelitis and No Visual Manifestations

  2008cited by this paper
• Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese.

  2007cited by this paper
• The spectrum of neuromyelitis optica.

  2007cited by this paper
• Interferon beta-1b exacerbates multiple sclerosis with severe optic nerve and spinal cord demyelination.

  2007cited by this paper
• Multiple Sclerosis

  2007cited by this paper
• Revised diagnostic criteria for neuromyelitis optica (NMO)

  2007cited by this paper
• Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica

  2007cited by this paper
• Revised diagnostic criteria for neuromyelitis optica

  2006cited by this paper
• The expression and function of chemokines involved in CNS inflammation.

  2006cited by this paper
• Multiple sclerosis--the plaque and its pathogenesis.

  2006cited by this paper
• Evidence for humoral autoimmunity in neuromyelitis optica

  2006cited by this paper
• Activation of humoral immunity and eosinophils in neuromyelitis optica

  2004cited by this paper
• Is Devic's neuromyelitis optica a separate disease? A comparative study with multiple sclerosis

  2003cited by this paper
• The two faces of IL-6 on Th1/Th2 differentiation.

  2002cited by this paper
• Increased IL-18 in patients with systemic lupus erythematosus: relations with Th-1, Th-2, pro-inflammatory cytokines and disease activity. IL-18 is a marker of disease activity but does not correlate with pro-inflammatory cytokines.

  2002cited by this paper
• Th1 dominance in HAM/TSP and the optico-spinal form of multiple sclerosis versus Th2 dominance in mite antigen-specific IgE myelitis.

  2000cited by this paper
• Interferon gamma production in blood lymphocytes correlates with disability score in multiple sclerosis patients

  2000cited by this paper
• Flow cytometric differentiation of Asian and Western types of multiple sclerosis, HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and hyperIgEaemic myelitis by analyses of memory CD4 positive T cell subsets and NK cell subsets.

  2000cited by this paper
• Multiple sclerosis.

  2000cited by this paper
• Interferon beta induces T-helper 2 immune deviation in MS

  1999cited by this paper
• The clinical course of neuromyelitis optica (Devic’s syndrome)

  1999cited by this paper
• Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis

  1999cited by this paper
• Antigenic peptides and autoimmunity

  1997cited by this paper
• Immune deviation towards Th2 inhibits Th-1-mediated autoimmune diabetes.

  1997influential reference
• Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis.

  1996cited by this paper
• Manipulation of the Th1/Th2 balance in autoimmune disease.

  1996cited by this paper
• Using gadolinium‐enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis

  1992cited by this paper
• Immunopathological recognition of autoantigens in multiple sclerosis.

  1991cited by this paper
• New diagnostic criteria for multiple sclerosis: Guidelines for research protocols

  1983cited by this paper
• CSF antibodies to myelin basic protein and to myelin‐associated glycoprotein in multiple sclerosis. Evidence of the intrathecal production of antibodies

  1983cited by this paper

• Analysis of changes in the chemokine CXC ligand 13 in serum and cerebrospinal fluid of patients with neuromyelitis optica

  2025cites this paper
• Increased level of GATA3-AS1 long non-coding RNA is correlated with the upregulation of GATA3 and IL-4 genes in multiple sclerosis patients

  2024cites this paper
• Relationship of immune cells with disability and cognitive impairment in patients with neuromyelitis optica spectrum disorder.

  2023cites this paper
• Interferon-γ controls aquaporin-4-specific Th17 and B cells in neuromyelitis optica spectrum disorder.

  2023cites this paper
• Clinical use of CSF neopterin levels in CNS demyelinating diseases.

  2022cites this paper
• VITAMIN D DEFICIENCY IN RELATION WITH THE SYSTEMIC AND CENTRAL INFLAMMATION DURING MULTIPLE SCLEROSIS

  2022cites this paper
• Vitamin D deficiency in relation with the systemic and central inflammation during multiple sclerosis

  2022cites this paper
• The association between body mass index, demographic and clinical characteristics with cognitive performance in patients with neuromyelitis optica spectrum disorder

  2022cites this paper
• Microstructural white matter abnormalities in multiple sclerosis and neuromyelitis optica spectrum disorders: Evaluation by advanced diffusion imaging.

  2022cites this paper
• A Comprehensive Review on the Role of Genetic Factors in Neuromyelitis Optica Spectrum Disorder

  2021cites this paper
• Th17-Related Cytokines as Potential Discriminatory Markers between Neuromyelitis Optica (Devic’s Disease) and Multiple Sclerosis—A Review

  2021cites this paper
• Metabolomic Profiling in Neuromyelitis Optica Spectrum Disorder Biomarker Discovery

  2020cites this paper
• Proteomic profiles of major serum proteins in seropositive NMO patients alter after Rituximab treatment

  2020cites this paper
• Low carbohydrate diet score and odds of neuromyelitis optica spectrum disorder: A case-control study.

  2020cites this paper
• Selective modulation of trans-endothelial migration of lymphocyte subsets in multiple sclerosis patients under fingolimod treatment.

  2020cites this paper
• The possible role of Interleukin-6 as a regulator of insulin sensitivity in patients with neuromyelitis optica spectrum disorder

  2020cites this paper
• Proteomic profiles of major serum proteins in seropositive NMO patients alter after Rituximab treatment

  2020cites this paper
• Peroxiredoxins are involved in the pathogenesis of multiple sclerosis and neuromyelitis optica spectrum disorder

  2020cites this paper
• Research status and progress of laboratory indexes related to neuromyelitis optica spectrum disorders

  2020influential citation
• The association between dietary sugar intake and neuromyelitis optica spectrum disorder: A case-control study.

  2019cites this paper
• Resolution of inflammation in neuromyelitis optica spectrum disorders.

  2019cites this paper
• Neuromyelitis optica spectrum disorder: Pathogenesis, treatment, and experimental models.

  2019cites this paper
• Low Serum Interleukin-10 Is an Independent Predictive Factor for the Risk of Second Event in Clinically Isolated Syndromes

  2019cites this paper
• Proportions of Th17 cells and Th17-related cytokines in neuromyelitis optica spectrum disorders patients: A meta-analysis.

  2019cites this paper
• Elevated serum level of IL-4 in neuromyelitis optica and multiple sclerosis patients

  2019cites this paper
• Cytokines and Tissue Damage Biomarkers in First-Onset Neuromyelitis Optica Spectrum Disorders: Significance of Interleukin-6

  2018cites this paper
• Elevated soluble syndecan‐1 levels in neuromyelitis optica are associated with disease severity

  2018cites this paper
• Condition-dependent generation of aquaporin-4 antibodies from circulating B cells in neuromyelitis optica

  2018cites this paper
• Condition-dependent generation of aquaporin-4 antibodies from circulating B cells in neuromyelitis optica

  2018cites this paper
• Altered humoral immunity to mycobacterial antigens in Japanese patients affected by inflammatory demyelinating diseases of the central nervous system

  2017cites this paper
• Th1 and Th17 Cells and Associated Cytokines Discriminate among Clinically Isolated Syndrome and Multiple Sclerosis Phenotypes

  2017cites this paper
• TGFβ1 transduction enhances immunomodulatory capacity of neural stem cells in experimental autoimmune encephalomyelitis

  2017cites this paper
• Th17 Cells Pathways in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders: Pathophysiological and Therapeutic Implications

  2016cites this paper
• CD 14 CD 16 monocytes are increased in patients with NMO and are selectively suppressed by glucocorticoids therapy

  2016cites this paper
• Biomarkers for neuromyelitis optica.

  2015cites this paper
• Association of circulating follicular helper T cells with disease course of NMO spectrum disorders.

  2015cites this paper
• Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation

  2015cites this paper
• Cytokines and Chemokines in Neuromyelitis Optica: Pathogenetic and Therapeutic Implications

  2014cites this paper
• Distinct serum apolipoprotein A-I levels in neuromyelitis optica and acute transverse myelitis

  2013cites this paper
• Post-acute serum eosinophil and neutrophil-associated cytokine/chemokine profile can distinguish between patients with neuromyelitis optica and multiple sclerosis; and identifies potential pathophysiological mechanisms - a pilot study.

  2013cites this paper
• Influence of regulatory T cells on remyelination in the central nervous system

  2013cites this paper